News for hackers. Stuff that matters.
Re:GPT‑Rosalind for life sciences research by XenophileJKO on Thursday April 16, 2026 @10:56PM (#47802026)
I would argue that while you still have failed trials, then we have room to improve trial vetting.

There are no comments on this comment yet.